S72.471S Torus fracture of lower end of right femur, sequela

Name of the Condition

• Torus fracture of lower end of right femur, sequela

Summary

This condition represents a torus (buckle) fracture of the distal (lower) end of the right femur, with documentation indicating a sequela phase. A torus fracture is an incomplete break characterized by buckling of the bone cortex, typically occurring in children due to the pliability of developing bones. The sequela phase denotes residual effects or complications following the healing of the initial fracture, such as persistent pain, limited mobility, or structural changes at the fracture site.

Causes

The initial torus fracture results from direct force or axial loading to the right femur, such as a fall onto the knee or a blow to the thigh. The sequela phase arises from incomplete resolution of the original injury, where healing may have left residual bone deformity, joint stiffness, or chronic pain. The underlying cause of the sequela is the prior fracture and its impact on bone and soft tissue healing.

Risk Factors

• Pediatric age group, as torus fractures are most common in children with developing bones.
• Inadequate initial treatment or rehabilitation, leading to prolonged healing or malunion.
• High-impact activities or sports that stress the affected limb, potentially exacerbating residual effects.
• Underlying bone conditions that may impair healing or increase fracture risk.

Symptoms

• Persistent localized pain or discomfort at the fracture site, even after initial healing.
• Reduced range of motion in the knee joint, potentially due to stiffness or deformity.
• Mild swelling or tenderness, particularly with activity or weight-bearing.
• Possible visible or palpable bone prominence at the fracture site.

Diagnosis

Clinical evaluation to assess residual symptoms, such as pain, stiffness, or deformity. Imaging studies, such as X-rays or MRI, to evaluate bone healing, joint alignment, and any persistent structural abnormalities. Correlation with prior fracture history and treatment records to confirm the sequela phase.

Treatment Options

Management focuses on addressing residual symptoms and improving function. This may include physical therapy to restore mobility and strength, pain management with medications or modalities, and orthopedic interventions if significant deformity or joint dysfunction is present. Surgical correction is rare but may be considered for severe malunion or persistent instability.

Prognosis and Follow-Up

Most patients experience gradual improvement in symptoms and function with appropriate care, though some residual limitations may persist. Follow-up visits monitor healing progress, functional recovery, and the need for ongoing therapy or adjustments to treatment. Long-term outcomes depend on the severity of the initial fracture and adherence to rehabilitation.

Complications

• Chronic pain or discomfort at the fracture site.
• Persistent joint stiffness or reduced mobility.
• Malunion or deformity affecting limb alignment.
• Increased risk of future fractures in the affected area due to altered bone structure.

Lifestyle & Prevention

• Avoid high-impact activities that stress the affected limb until cleared by a healthcare provider.
• Engage in low-impact exercises, such as swimming or cycling, to maintain mobility and strength.
• Use protective gear during sports or activities to prevent re-injury.
• Follow a balanced diet rich in calcium and vitamin D to support bone health.

When to Seek Professional Help

Seek care if symptoms worsen, new pain or swelling develops, or mobility significantly decreases. Prompt evaluation is necessary if signs of infection, severe deformity, or nerve compression occur, as these may require urgent intervention.

Tips for Medical Coders

Document the sequela phase clearly, including evidence of residual effects from the prior torus fracture. Ensure the code S72.471S is used only when the condition is a direct result of the initial fracture and not an unrelated issue. Include details on the nature of the residual symptoms (e.g., pain, stiffness) and any ongoing treatment to support the sequela designation.